Eventide Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134M | Buy |
2,637,485
+110,485
| +4% | +$5.62M | 2.35% | 4 |
|
|
2025
Q1 | $114M | Sell |
2,527,000
-79,938
| -3% | -$3.6M | 2.27% | 4 |
|
|
2024
Q4 | $108M | Sell |
2,606,938
-838,425
| -24% | -$34.7M | 1.96% | 6 |
|
|
2024
Q3 | $134M | Sell |
3,445,363
-169,457
| -5% | -$6.61M | 2.32% | 6 |
|
|
2024
Q2 | $124M | Buy |
3,614,820
+314,420
| +10% | +$10.8M | 2.12% | 8 |
|
|
2024
Q1 | $82.9M | Buy |
3,300,400
+636,751
| +24% | +$16M | 1.3% | 25 |
|
|
2023
Q4 | $78.6M | Sell |
2,663,649
-1,294,930
| -33% | -$38.2M | 1.28% | 27 |
|
|
2023
Q3 | $125M | Buy |
3,958,579
+499,378
| +14% | +$15.8M | 2.25% | 7 |
|
|
2023
Q2 | $89.5M | Buy |
3,459,201
+1,400,000
| +68% | +$36.2M | 1.51% | 18 |
|
|
2023
Q1 | $49.5M | Buy |
2,059,201
+2,201
| +0.1% | +$52.9K | 0.91% | 37 |
|
|
2022
Q4 | $40.1M | Buy |
2,057,000
+782,000
| +61% | +$15.2M | 0.79% | 44 |
|
|
2022
Q3 | $26.8M | Buy |
+1,275,000
| New | +$26.8M | 0.53% | 62 |
|